# 4D Molecular Therapeutics, Inc.: Form 8-K, filed Aug 12, 2021

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2021-08-12
- Accepted by EDGAR: Aug 12, 2021, 16:16 ET
- Period: 2021-08-12
- Accession: 0001564590-21-043986
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000156459021043986/fdmt-8k_20210812.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000156459021043986/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000156459021043986/fdmt-8k_20210812.htm

Filed Aug 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-043986. Last ingested by Listed: Nov 10, 2026, 16:32 ET. No prices; not investment advice.